BetterLife Pharma Inc C.BETR

Alternate Symbol(s): BETRF

Healthcare

BetterLife Pharma Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001 is a non-hallucinogenic Lysergic Acid Diethylamide (LSD) derivative. BETR-001 mimics the projected therapeutic properties of LSD without causing its undesirable side effects such as hallucinations and cardiac toxicity. BETR-001 is a therapy to treat debilitating psychiatric disorders with high unmet need, such as major depressive disorder and anxiety disorders; as well as neurological disorders such as neuropathic pain. BETR-002 is a formulation of a derivative of dihydrohonokiol, a known anti-anxiety compound for treatment of benzodiazepine dependency, anxiety and spasticity. The Company also owns a drug candidate for the treatment of viral infections such as COVID-19. The Company’s subsidiaries include MedMelior Inc., BetterLife Pharma US Inc. and Blife Therapeutics Inc.

CSE:BETR - Post by User

BetterLife Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by rixpixon Mar 08, 2024 1:09pm

70 Views

Post# 35923111

Ok, Trying 1 more time to buy 250 thousand shares

I just entered another 2 orders to buy 250K shares @ 7.5 cents even though I prefer to buy at the ask when the SP reaches my buy price.I put it in, good for a couple of days with RBC.

If someone wants to sell or reduce their holdings feel free to fill the orders.

GLTA

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market